AMR SVG Icons location

Managing Trace Elements in Parenteral Nutrition

A new website providing educational content and treatment guidelines

Explore Now

Dedicated to Alleviating Drug Shortages

We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients.

Learn more

Check Product Availability

Updated May 29, 2023

View All
HydrALAZINE Hydrochloride Vial Image

HydrALAZINE Hydrochloride

  • 20 mg/mL | 1 mL Single Dose Vial
  • Shelf Pack — 25
Papaverine HCL Vial Image

Papaverine HCL

  • 30 mg/mL | 2 mL Single Dose Vial
  • Shelf Pack — 25
Zinc Sulfate Vial Image

Zinc Sulfate

  • 5 mg/mL | 5 mL Pharmacy Bulk Package Vial
  • Shelf Pack — 25

News Center

American Regent® Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)

Melville, NY – May 2, 2023: American Regent® is pleased to announce the launch of Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)

American Regent introduces FDA-approved Epinephrine Injection, USP

Melville, NY – March 23, 2023: American Regent announces the launch of sulfite-free Epinephrine Injection, USP.

HBT Labs, Inc. to Join American Regent, Inc

Shirley, NY – American Regent, Inc., a U.S. manufacturer of pharmaceuticals for human and veterinary use with manufacturing sites in New York and Ohio, today announced it acquired HBT Labs, Inc. based in California.

Contact Us

Request for Medical Information Request a Grant Investigator Initiated Study Request a Certificate of Analysis Expanded Access Policy
Find a Distributor
Please choose your preferred method of contact

By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. If at any time you wish your personal information to be removed from the American Regent® database, please submit a message request to corpcommunications@americanregent.com.